What reliable handling information names

  • Exact formulation and concentration.
  • Container and light-protection requirements.
  • Tested temperature range and time period.
  • Compatibility with the stated vehicle and other ingredients.

What this evidence review covers

Explain why GHK-Cu storage depends on exact product form and stability data.

  • Product-form matrix
  • Container/light/temperature/time variables
  • Unopened versus prepared product
  • No generic shelf life
  • Anecdotal 'purge' query belongs on safety, not storage

Source-backed findings

Each claim below is tied to the evidence class that can support it. Commercial listing data and clinical evidence remain separate.

source limitation

Experimental formulations in primary studies cannot set storage for unrelated commercial products.

regulatory

Injectable formulation quality is a distinct regulatory concern.

Evidence classWhat the source supports
source limitationExperimental formulations in primary studies cannot set storage for unrelated commercial products.
regulatoryInjectable formulation quality is a distinct regulatory concern.

Source-by-source evidence notes

These notes state what each inspected source can support and the boundary that should not be crossed when interpreting it.

GHK-Cu stimulation of collagen synthesis in fibroblast culture

Evidence class: primary in vitro. What it supports: Collagen synthesis under defined cell-culture conditions.

What it does not establish: Clinical skin, hair, wound, or injectable outcomes.

GHK-Cu connective-tissue accumulation in rat experimental wounds

Evidence class: primary animal. What it supports: Extracellular-matrix findings in a rat wound model.

What it does not establish: Human treatment outcomes or injectable dosing.

FDA bulk substances that may present significant safety risks

Evidence class: primary regulatory. What it supports: FDA's BPC-157, injectable GHK-Cu, and TB-500 fragment safety/characterization statements; no identified human TB-500 fragment exposure data.

What it does not establish: A diagnosis, individual risk estimate, or claim that topical GHK-Cu and injectable GHK-Cu share one risk profile.

Questions this page answers

Does all GHK-Cu need refrigeration?

No universal answer is supported; follow validated documentation for the exact form and container.

How long is prepared GHK-Cu stable?

Do not state a duration without product-specific chemical and microbiological stability evidence.

What remains unresolved

  • No stability dossiers for tracked listings.
  • No independent degradation studies.
  • Misassigned 'copper uglies' query should be redirected to safety/research rather than answered here.